2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity

Details for Australian Patent Application No. 2005267706 (hide)

International Classifications

Event Publications

22 March 2007 PCT application entered the National Phase

PCT publication WO2006/015357 Priority application(s): WO2006/015357

1 December 2011 Assignment before Grant

University of Virginia Patent Foundation; Adenosine Therapeutics LLC The application has been assigned to University of Virginia Patent Foundation

8 December 2011 Application Accepted

Published as AU-B-2005267706

5 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.